Ftse Mib
35.366,37
0,61%
DAX
18.869,36
0,78%
S&P 500
5.308,21
1,17%
NASDAQ
16.739,01
1,38%
Bitcoin
66.153,78
7,48%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Renalytix PLC (RNLX) Renalytix PLC (RNLX) Notizie

Renalytix PLC

RNLX
0,5664
-0,0986 (-14,83%)
Ultimo aggiornamento: 21:44:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/5/202416:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/5/202415:23EDGAR2Form 8-K - Current report
15/5/202413:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202413:00EDGAR2Form 8-K - Current report
15/5/202413:00GLOBERenalytix Reports Financial Results for Third Quarter of..
09/5/202413:00GLOBERenalytix to Report Financial Results for Third Quarter..
08/4/202413:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
14/3/202412:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
15/2/202413:00GLOBERenalytix Reports Financial Results for Second Quarter of..
15/2/202413:00EDGAR2Form 8-K - Current report
14/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202415:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
17/1/202413:15EDGAR2Form 8-K - Current report
10/1/202413:15EDGAR2Form 8-K - Current report
10/1/202413:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
29/12/202322:02EDGAR2Form 8-K - Current report
17/11/202322:01EDGAR2Form ARS - Annual Report to Security Holders
14/11/202313:00GLOBERenalytix Reports Financial Results for First Quarter of..
07/11/202313:00GLOBERenalytix to Report Financial Results for First Quarter..
03/11/202321:04EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202314:00EDGAR2Form 8-K - Current report
06/10/202313:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
28/9/202313:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
25/9/202313:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
08/9/202322:04EDGAR2Form 8-K - Current report
07/9/202313:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
03/8/202313:00GLOBERenalytix Clinical Advisory Board Formed to Support..
21/7/202313:00GLOBERenalytix Announces Middle East Distribution Agreement with..
07/7/202313:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
03/7/202313:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
30/6/202300:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
30/6/202300:01GLOBEFDA Grants De Novo Marketing Authorization for..
15/6/202313:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
09/6/202313:00GLOBERenalytix Reports Financial Results for Third Quarter of..
05/6/202313:00GLOBERenalytix to Report Third Quarter Fiscal Year 2023 Financial..
25/5/202313:00GLOBERenalytix selects EVERSANA® to expand commercialization of..
Apertura: 0,665 Min: 0,5116 Max: 0,68
Chiusura: 0,665

La tua Cronologia

NASDAQ
RNLX
Renalytix
BOV
VLRA7L
Agropecuaria Vale Rio Acre PNC
USOTC
VFRM
Veritas Farms (QB)
COIN
ITGRUSD
Integral
NYSE
CXR
Cox Radio A
BITV
FXSEUR
Frax Share
BIT
P1SO04
BNP Paribas Issuance
BIT
UC1MXG
Unicredit Bank
BIT
P10W06
Bnp Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network